Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-trimoxazole in Severe COVID-19
NCT04470531Phase 2Unknown
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Jul 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trimethoprim + sulfamethoxazole in coronavirus disease 2019 (COVID-19), sponsored by Bangabandhu Sheikh Mujib Medical University. Status: unknown.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04470531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04470531.